Clinicogenomic analysis of FGFR2-rearranged cholangiocarcinoma identifies correl
- This topic has 0 replies, 1 voice, and was last updated 3 years, 5 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Clinicogenomic analysis of FGFR2-rearranged cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib
https://pubmed.ncbi.nlm.nih.gov/33218975/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.